TREATMENT OF GASTRIC INFLAMMATORY DISEASE WITH¹CYTOPROTECTIVE PROSTAGLANDINS AND HISTAMINE-2 BLOCKING¹ANTI-SECRETARY AGENTS

• 1. 用于治疗炎性疾病的抗胆碱能药、糖皮质激素、β₂-激动剂、PDE4抑制剂和抗白细胞三烯药的组合 [P] . 中国专利： CN101321539B . 2010.09.29
• 2. 用于治疗炎性疾病的抗胆碱能药、糖皮质激素、β₂－激动剂、PDE4抑制剂和抗白细胞三烯药的组合 [P] . 中国专利： CN101321539A . 2008-12-10
• 3. TREATMENT OF GASTRIC INFLAMMATORY DISEASE WITH CYTOPROTECTIVE PROSTAGLANDINS AND HISTAMINE-2 RECEPTOR BLOCKING ANTI-SECRETORY AGENTS [P] . ZA838265B . 1984-09-26

  机译： 细胞保护性前列腺素和HISTAMINE-2受体阻滞抗炎剂治疗胃炎性疾病

• 4. Treatment of gastric inflammatory disease with cytoprotective prostaglandins and histamine-2 blocking anti-secretory agents [P] . 欧洲知识产权局专利： EP0108452A1 . 1984-05-16

  机译： 细胞保护性前列腺素和组胺2阻断抗分泌剂治疗胃炎

• 5. TREATMENT OF GASTRIC INFLAMMATORY DISEASE WITH CYTOPROTECTIVE PROSTAGLANDINS AND HISTAMIN-2 RECEPTOR BLOCKING ANTI-SECRETORY AGENTS [P] . CA1209044A . 1986-08-05

  机译： 细胞保护性前列腺素和HISTAMINE-2受体阻滞抗炎剂治疗胃炎性疾病

• 1. Potent and selective 2-oxoamide inhibitors of phospholipases A2 as novel medicinal agents for the treatment of inflammatory diseases [C] . Efrosini Barbayianni, Georgia Antonopoulou, George Kokotos IUPAC World Congress on Chemistry . 2015
• 2. Discovery and Pharmacological Study of Drug Candidate Agents for the Treatment of Inflammatory Diseases [D] . 脇田 久嗣 2019
• 3. Antioxidant and gastric cytoprotective prostaglandins properties of Cassia sieberiana roots bark extract as an anti-ulcerogenic agent [O] . Edmund T Nartey, Mark Ofosuhene, William Kudzi, 2012
• 4. Antioxidant and gastric cytoprotective prostaglandins properties of Cassia sieberiana roots bark extract as an anti-ulcerogenic agent [O] . Nartey Edmund T, Ofosuhene Mark, Kudzi William, 2012

• 1. Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease? [J] . Hitoshi Asakura ,Kenji Suzuki ,Terasu Honma . 世界胃肠病学杂志：英文版 . 2007,第15期
• 2. Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment [J] . Naser-Aldin Lashgari ,Nazanin Momeni Roudsari ,Saeideh Momtaz . 世界胃肠病学杂志:英文版 . 2021,第46期
• 3. Exploitation of the nicotinic anti-inflammatory pathway for the treatment of epithelial inflammatory diseases [J] . David A Scott ,Michael Martin . 世界胃肠病学杂志：英文版 . 2006,第46期
• 4. Exacerbation of chronic inflammatory diseases by infectious agents:Fact or fiction? [J] . Bernhard Kaltenboeck . 世界糖尿病杂志：英文版（电子版） . 2010,第2期
• 5. Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease [J] . David G Cox ,J Bart A Crusius ,Petra HM Peeters . 世界胃肠病学杂志：英文版 . 2005,第38期
• 6. 抗组胺治疗对组胺诱导的皮肤微血管内皮细胞通透性改变的作用研究 [C] . 付丽新 ,陈涛 . 第十届四川·重庆皮肤性病学术会议暨四川省医学会第十三次皮肤性病学术会议 . 2016
• 7. 钠氢交换体及其阻断剂在高盐诱导乳鼠心肌成纤维细胞增殖、胶原分泌和钙离子调控中的作用 [A] . 孙雅 . 2018